말 의약품 및 보충제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 유통 채널별, 지역별, 경쟁별(2020-2030년)

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,256,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,646,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,122,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 말 의약품·보충제 시장 규모는 2024년에 9억 7,289만 달러에 달하며, 2030년까지 연간 평균 성장률(CAGR)은 5.90%로 예측되며, 예측 기간 중 대폭적인 성장이 전망되고 있습니다. 이 시장에는 말의 건강과 복지를 증진하기 위한 다양한 제품과 서비스가 포함됩니다. 이 시장에는 말의 건강 유지, 성능 향상, 다양한 질병에 대처하기 위해 말 전용으로 설계된 의약품, 영양 보충제, 헬스케어 서비스가 포함됩니다. 예를 들어 2024년 3월 미국 말의학회(AAEP)는 미국에서 유행하는 5가지 중요한 말 질병(서나일 바이러스, 파상풍, 말 뇌척수염, 광견병)에 대한 최신 백신 접종 프로토콜을 발표하였습니다. 이들 질병에는 예방 활동을 강화하고 전국 말의 건강과 안전을 보장하기 위한 프로토콜이 마련되어 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	9억 7,289만 달러
시장 규모 : 2030년	13억 6,115만 달러
CAGR: 2025-2030년	5.90%
급성장 부문	의약품
최대 시장	북미

주요 시장 성장 촉진요인

말의 개체수 증가

주요 시장 이슈

위조품

주요 시장 동향 :

천연 및 허브 보충제

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 말 의약품·보충제 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별(의약품, 보충제)
  • 유통 채널별(드러그스토어, 동물병원, 기타)
  • 지역별
  • 기업별(2024년)
• 제품 시장 맵
  • 제품별
  • 유통 채널별
  • 지역별

제6장 북미의 말 의약품·보충제 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 캐나다
  • 멕시코

제7장 유럽의 말 의약품·보충제 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 말 의약품·보충제 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 말 의약품·보충제 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 말 의약품·보충제 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Zoetis Inc
• Boehringer Ingelheim GmbH
• Merck & Co Inc
• Elanco Animal Health Inc
• Bayer AG
• Ceva Sante Animale SA
• Virbac SA
• Vetoquinol SA
• Affymetrix Inc
• Celltrion Inc

제15장 전략적 제안

제16장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

The global Equine Pharmaceuticals & Supplements market was valued at USD 972.89 million in 2024 and is expected to experience substantial growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market includes a wide range of products and services aimed at promoting the health and well-being of horses. It encompasses pharmaceuticals, nutritional supplements, and healthcare services specifically designed for equines, with the goal of maintaining their health, improving performance, and addressing various medical conditions. For example, in March 2024, the American Association of Equine Practitioners (AAEP) released updated vaccination protocols for five critical equine diseases prevalent in the U.S. These diseases-West Nile virus, tetanus, equine encephalomyelitis, and rabies-have protocols designed to improve prevention efforts and ensure the health and safety of horses nationwide.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 972.89 Million
Market Size 2030	USD 1361.15 Million
CAGR 2025-2030	5.90%
Fastest Growing Segment	Pharmaceutical
Largest Market	North America

Key Market Drivers:

Increasing Equine Population

The global equine industry has seen a notable and steady rise in the equine population, which has significantly influenced the growth of the Equine Pharmaceuticals & Supplements market. There has been a marked increase in participation in equestrian activities such as horse riding, show jumping, and dressage, leading to a higher demand for horses for both sporting and recreational purposes. Beyond sports and leisure, horses are vital in industries such as agriculture, tourism, therapy, and law enforcement. As these sectors grow, the need for a larger equine workforce has also increased. Additionally, horses have become increasingly popular as companion animals, contributing to a surge in ownership.

Key Market Challenges:

Counterfeit Products

The presence of counterfeit equine pharmaceuticals and supplements remains a significant challenge. These products are often of subpar quality, containing incorrect ingredients or dosages, which could endanger the health of horses and undermine consumer confidence in the market.

Key Market Trends:

Natural and Herbal Supplements

A growing trend within the equine supplements market is the rising demand for natural and herbal alternatives. Horse owners are increasingly seeking holistic solutions to equine health, opting for supplements made from herbs, botanicals, and plant-based ingredients known for their therapeutic benefits. These products are perceived as gentler alternatives to conventional pharmaceuticals.

Key Market Players:

• Zoetis Inc
• Boehringer Ingelheim GmbH
• Merck & Co Inc
• Elanco Animal Health Inc
• Bayer AG
• Ceva Sante Animale SA
• Virbac SA
• Vetoquinol SA
• Affymetrix Inc
• Celltrion Inc

Report Scope:

This report segments the global Equine Pharmaceuticals & Supplements market into the following categories, and provides insights into the industry trends:

By Product:

• Pharmaceuticals
• Supplements

By Distribution Channel:

• Drug Stores
• Veterinary Hospitals
• Other Channels

By Region:

• North America: United States, Canada, Mexico
• Europe: Germany, United Kingdom, France, Italy, Spain
• Asia-Pacific: China, Japan, India, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides a detailed analysis of the key players in the global Equine Pharmaceuticals & Supplements market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the Global Equine Pharmaceuticals & Supplements market, catering to individual business needs. Customization options include the profiling and analysis of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Pharmaceuticals & Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Pharmaceutical, Supplement)
  • 5.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Distribution Channel
  • 5.3.3. By Region

6. North America Equine Pharmaceuticals & Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Pharmaceutical, Supplement)
  • 6.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Pharmaceuticals & Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Canada Equine Pharmaceuticals & Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Mexico Equine Pharmaceuticals & Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Distribution Channel

7. Europe Equine Pharmaceuticals & Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Pharmaceutical, Supplement)
  • 7.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Pharmaceuticals & Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. United Kingdom Equine Pharmaceuticals & Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. France Equine Pharmaceuticals & Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. Italy Equine Pharmaceuticals & Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Equine Pharmaceuticals & Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Equine Pharmaceuticals & Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Pharmaceutical, Supplement)
  • 8.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Equine Pharmaceuticals & Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. Japan Equine Pharmaceuticals & Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. India Equine Pharmaceuticals & Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. Australia Equine Pharmaceuticals & Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. South Korea Equine Pharmaceuticals & Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Distribution Channel

9. South America Equine Pharmaceuticals & Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Pharmaceutical, Supplement)
  • 9.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Pharmaceuticals & Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. Argentina Equine Pharmaceuticals & Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. Colombia Equine Pharmaceuticals & Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Equine Pharmaceuticals & Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Pharmaceutical, Supplement)
  • 10.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Pharmaceuticals & Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Pharmaceuticals & Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. UAE Equine Pharmaceuticals & Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Distribution Channel
  • 10.3.4. Kuwait Equine Pharmaceuticals & Supplements Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc
• 14.2. Boehringer Ingelheim GmbH
• 14.3. Merck & Co Inc
• 14.4. Elanco Animal Health Inc
• 14.5. Bayer AG
• 14.6. Ceva Sante Animale SA
• 14.7. Virbac SA
• 14.8. Vetoquinol SA
• 14.9. Affymetrix Inc
• 14.10. Celltrion Inc

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료